A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995

The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product

Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017

Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53

Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456

Cyclin is degraded by the ubiquitin pathway

Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,359

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403

Structural Insights into a Wildtype Domain of the Oncoprotein E6 and Its Interaction with a PDZ Domain

Mischo, A., Ohlenschläger, O., Hortschansky, P., Ramachandran, R., & Görlach, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062584 · Cited by 24

CANCER BIOLOGY: The human papillomavirus E6/E7 genes induce discordant changes in the expression of cell growth regulatory proteins

Pei, X. F. (1996) · Carcinogenesis · doi:10.1093/carcin/17.7.1395 · Cited by 24

The molecular biology of cervical cancer

Münger, K. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590908 · Cited by 24

Transforming properties of the cottontail rabbit papillomavirus oncoproteins Le6 and SE6 and of the E8 protein

Harry, J. B., & Wettstein, F. O. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3355-3362.1996 · Cited by 24

Ubiquitin in signal transduction and cell transformation

Isaksson, A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00011-x · Cited by 24

A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix

Nakagawa, S., Yoshikawa, H., Kimura, M., Kawana, K., Matsumoto, K., Onda, T., Kino, N., Yamada, M., Yasugi, T., & Taketani, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690093 · Cited by 24

Human Papillomavirus 58 E7 T20I/G63S Variant Isolated from an East Asian Population Possesses High Oncogenicity

Boon, S. S., Xia, C., Lim, J. Y., Chen, Z., Law, P. T. Y., Yeung, A. C. M., Thomas, M., Banks, L., & Chan, P. K. S. (2020) · Journal of Virology · doi:10.1128/jvi.00090-20 · Cited by 23

Targeting Aberrant Expression of STAT3 and AP-1 Oncogenic Transcription Factors and HPV Oncoproteins in Cervical Cancer by Berberis aquifolium

Singh, T., Chhokar, A., Thakur, K., Aggarwal, N., Pragya, P., Yadav, J., Tripathi, T., Jadli, M., Bhat, A., Gupta, P. K., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.757414 · Cited by 23

Human papillomavirus 16E6 and NFX1-123 potentiate notch signaling and differentiation without activating cellular arrest

Vliet-Gregg, P. A., Hamilton, J. R., & Katzenellenbogen, R. A. (2015) · Virology · doi:10.1016/j.virol.2015.02.002 · Cited by 23

E6AP is required for replicative and oncogene-induced senescence in mouse embryo fibroblasts

Levav-Cohen, Y., Wolyniec, K., Alsheich-Bartok, O., Chan, A.-L., Woods, S. J., Jiang, Y.-H., Haupt, S., & Haupt, Y. (2011) · Oncogene · doi:10.1038/onc.2011.402 · Cited by 20

The prognostic value of p53 expression for patients with cervical cancer: a meta analysis

Zhou, R., Wei, C., Liu, J., Luo, Y., & Tang, W. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.10.006 · Cited by 23

Lens Crystallins

Duncan, M. K., Cvekl, A., Kantorow, M., & Piatigorsky, J. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.006 · Cited by 23

The dual function steroid receptor coactivator/ubiquitin protein-ligase integrator E6-AP is overexpressed in mouse mammary tumorigenesis

Sivaraman, L., Nawaz, Z., Medina, D., Conneely, O. M., & O’Malley, B. W. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006410111706 · Cited by 22

Molecular analysis of the interaction between HPV type 16 E6 and human E6‐associated protein

Daniels, P. R., Sanders, C. M., Coulson, P. S., & Maitland, N. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01160-5 · Cited by 23

The roles of programmed death ligand 1 in virus-associated cancers

Mofrad, M. G., Maleki, D. T., & Faghihloo, E. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104368 · Cited by 23

HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition

Nie, G., Tang, B., Lv, M., Li, D., Li, T., Ou, R., Xu, Y., & Wen, J. (2023) · Cell Biology International · doi:10.1002/cbin.12020 · Cited by 22

Human Papillomavirus E6 and E7 Oncogenes

Münger, K., Howley, P. M., & DiMaio, D. (2007) · Springer eBooks · doi:10.1007/978-0-387-36523-7_10 · Cited by 21

Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens.

Kuramoto, H., Hongo, A., Liu, Y.-X., Ojima, Y., Nakamura, K., Seki, N., Kodama, J., & Hiramatsu, Y. (2008) · PubMed · doi:10.18926/amo/30944 · Cited by 22

Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle

Lee, C.-H., Wooldridge, T. R., & Laimins, L. A. (2006) · Virology · doi:10.1016/j.virol.2006.08.028 · Cited by 22

Modifying effect of MDM4 variants on risk of HPV16‐associated squamous cell carcinoma of oropharynx

Yu, H., Sturgis, E. M., Liu, Z., Wang, L., Wei, Q., & Li, G. (2011) · Cancer · doi:10.1002/cncr.26423 · Cited by 22

Characterization of the BUD31 gene of Saccharomyces cerevisiae

Masciadri, B., Areces, L. B., Carpinelli, P., Foiani, M., Draetta, G. F., & Fiore, F. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.228 · Cited by 22

Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53

Löber, C., Lenz-Stöppler, C., & Dobbelstein, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-2047 · Cited by 22

A plant lignan, 3′‐O‐Methyl‐Nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells

Allen, K. L., Tschantz, D. R., Awad, K. S., Lynch, W. P., & DeLucia, A. L. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20305 · Cited by 22

Gene activation by the AraC protein can be inhibited by DNA looping between AraC and a LexA repressor that interacts with AraC: possible applications as a two‐hybrid system

Kornacker, M. G., REMSBURG, B., & Menzel, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01096.x · Cited by 22

Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.

Gardiol, D., & Banks, L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-8-1963 · Cited by 22

Lens Induction and Determination

Fisher, M. A., & Grainger, R. M. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.003 · Cited by 22

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Offensperger, F., Müller, F., Jansen, J., Hammler, D., Götz, K., Marx, A., Sirois, C. L., Chamberlain, S. J., Stengel, F., & Scheffner, M. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.08.017 · Cited by 21

The Involvement of Human Papilloma Virus in Gastrointestinal Cancers

Baj, J., Forma, A., Dudek, I., Chilimoniuk, Z., Dobosz, M., Dobrzyński, M., Teresiński, G., Buszewicz, G., Flieger, J., & Portincasa, P. (2022) · Cancers · doi:10.3390/cancers14112607 · Cited by 21

Regulation of HPV E7 Stability by E6-Associated Protein (E6AP)

Vats, A., Trejo-Cerro, Ó., Massimi, P., & Banks, L. (2022) · Journal of Virology · doi:10.1128/jvi.00663-22 · Cited by 24

Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides

Stutz, C., Reinz, E., Honegger, A., Bulkescher, J., Schweizer, J., Zanier, K., Travé, G., Lohrey, C., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132339 · Cited by 21

Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex

Masuda, Y., Saeki, Y., Arai, N., Kawai, H., Kukimoto, I., Tanaka, K., & Masutani, C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008374 · Cited by 21

Lens Fiber Differentiation

Bassnett, S., & Beebe, D. C. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.010 · Cited by 21

Transgenic models of retinoblastoma: what they tell us about its cause and treatment.

Albert, D. M., Griep, A. E., Lambert, P. F., Howes, K. A., Windle, J. J., & Lasudry, J. (1994) · PubMed Central · Cited by 21

The Virology of Cervical Neoplasia

Stoler, M. H. (2003) · The Cancer Journal · doi:10.1097/00130404-200309000-00005 · Cited by 21

Development of peptide aptamer microarrays for detection of HPV16 oncoproteins in cell extracts

Laurenson, S. X., Pett, M. R., Hoppe‐Seyler, K., Denk, C., Hoppe‐Seyler, F., Coleman, N., & Ferrigno, P. K. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.10.038 · Cited by 20

Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease

Romero-Masters, J. C., Lambert, P. F., & Münger, K. (2022) · Viruses · doi:10.3390/v14102138 · Cited by 22

Early upregulation of cyclooxygenase‐2 in human papillomavirus type 16 and telomerase‐induced immortalization of human esophageal epithelial cells

Zhuang, Z., Tsao, S., Deng, W., Wang, J., Xia, H. H., He, H., Feng, H., Wang, L., Gu, Q., Lam, S. G., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05509.x · Cited by 20

Expression of p53, p21 CIP1/WAF1 and eIF4E in the adjacent tissues of oral squamous cell carcinoma: establishing the molecular boundary and a cancer progression model

Li, Y., Li, B., Xu, B., Han, B., Xia, H., Chen, Q., & Li, L. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2015.5 · Cited by 20

The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis

Romeo, M., Hutchison, T., Malu, A., White, A., Kim, J., Gardner, R., Smith, K., Nelson, K., Bergeson, R., McKee, R., et al. (2018) · Virology · doi:10.1016/j.virol.2018.02.010 · Cited by 20

Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells

Vázquez-Ortíz, G., GARCÍA, J. A., Ciudad, C. J., Noé, V., Peñuelas, S., López-Romero, R., Mendoza‐Lorenzo, P., Piña‐Sánchez, P., & Salcedo, M. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00831.x · Cited by 20

Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response

Mathieu, N. A., Levin, R. H., & Spratt, D. E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.659049 · Cited by 22

The potential of PCNA inhibition as a therapeutic strategy in cervical cancer

Wendel, S. O., Snow, J. A., Gu, L., Banerjee, N. S., Malkas, L. H., & Wallace, N. A. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29244 · Cited by 19

Activation of E6AP/UBE3A-Mediated Protein Ubiquitination and Degradation Pathways by a Cyclic γ-AA Peptide

Huang, B., Zhou, L., Liu, R., Wang, L., Xue, S., Shi, Y., Jeong, G. H., Jeong, I. H., Li, S., Yin, J., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01922 · Cited by 20

Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus

Beck, G. R., Zerler, B. R., & Morán, E. (2014) · ASM Press eBooks · doi:10.1128/9781555818289.ch2 · Cited by 19

A Literature Review on the Antiviral Mechanism of Luteolin

Lu, P., Zhang, T., Ren, Y., Rao, H., Lei, J., Zhao, G., Wang, M., Gong, D., & Cao, Z. (2023) · Natural Product Communications · doi:10.1177/1934578x231171521 · Cited by 19

Cellular Players in the Herpes Simplex Virus Dependent Apoptosis Balancing Act

Nguyen, M. L., & Blaho, J. A. (2009) · Viruses · doi:10.3390/v1030965 · Cited by 19

Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification

Hong, S., Cheng, S., Songock, W. K., Bodily, J. M., & Laimins, L. A. (2017) · Journal of Virology · doi:10.1128/jvi.01712-17 · Cited by 18

Human papillomavirus oncoproteins and post-translational modifications: generating multifunctional hubs for overriding cellular homeostasis

Basukala, O., Sarabia-Vega, V., & Banks, L. (2020) · Biological Chemistry · doi:10.1515/hsz-2019-0408 · Cited by 18

Infection à Papillomavirus humains

Aubin, F., Prétet, J., Mougin, C., & Riethmuller, D. (2007) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(07)89005-3 · Cited by 18

The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytes

Stöppler, H., Malerczyk, C., Block, K., Aigner, A. M., & Czubayko, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204957 · Cited by 18

Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells

Nakamura, S., Roth, J. A., & Mukhopadhyay, T. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205343 · Cited by 18

Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway via degradation of RIG-I and MDA5

Weerawardhana, A., Uddin, M. B., Choi, J.-H., Pathinayake, P. S., Shin, S. H., Chathuranga, K., Park, J.-H., & Lee, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020262 · Cited by 17

Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptides

Tokareva, O. S., Li, K., Travaline, T. L., Thomson, T. M., Swiecicki, J., Moussa, M., Ramirez, J. D., Litchman, S., Verdine, G. L., & McGee, J. H. (2023) · Nature Communications · doi:10.1038/s41467-023-42395-z · Cited by 20

The Human Papillomavirus E7 Proteins Associate with p190RhoGAP and Alter Its Function

Todorovic, B., Nichols, A. C., Chitilian, J. M., Myers, M. P., Shepherd, T. G., Parsons, S. J., Barrett, J. W., Banks, L., & Mymryk, J. S. (2014) · Journal of Virology · doi:10.1128/jvi.03263-13 · Cited by 17

Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly

Boon, S. S., Chen, Z., Li, J., Lee, K. Y. C., Cai, L., Zhong, R., & Chan, P. K. S. (2019) · BMC Cancer · doi:10.1186/s12885-019-6413-7 · Cited by 17

Prevalence and Prognostic Impact of Equus caballus Papillomavirus Type 2 Infection in Equine Squamous Cell Carcinomas in Western Canadian Horses

Greenwood, S., Chow-Lockerbie, B., Epp, T. Y., Knight, C. G., Wachoski-Dark, G. L., MacDonald‐Dickinson, V., & Wobeser, B. K. (2020) · Veterinary Pathology · doi:10.1177/0300985820941266 · Cited by 17

MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer

Gardiner, A. S., McBee, W. C., Edwards, R. P., Austin, M., Lesnock, J. L., Bhargava, R., Guido, R. S., & Khan, S. A. (2010) · Infectious Agents and Cancer · doi:10.1186/1750-9378-5-s1-a55 · Cited by 17

Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells

Plissonnier, M., Fauconnet, S., Bittard, H., Mougin, C., Rommelaere, J., & Lascombe, I. (2017) · Oncotarget · doi:10.18632/oncotarget.22632 · Cited by 20

Ubiquitylation within signaling pathways in- and outside of inflammation

Hochrainer, K., & Lipp, J. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-08-0471 · Cited by 17

Complementation of a p300/CBP defective-binding mutant of adenovirus E1a by human papillomavirus E6 proteins

Bernat, A., Massimi, P., & Banks, L. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-4-829 · Cited by 17

A sequence element of p53 that determines its susceptibility to viral oncoprotein-targeted degradation

Gu, J., Rubin, R. M., & Yuan, Z.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204454 · Cited by 17

Analysis of the p53-Mediated G 1 Growth Arrest Pathway in Cells Expressing the Human Papillomavirus Type 16 E7 Oncoprotein

Leanne, D. K., & Munger, J. A. (1997) · Cited by 17

p53 as the main traffic controller of the cell signaling network

Sebastian, S. (2010) · Frontiers in bioscience · doi:10.2741/3669 · Cited by 16

Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases

Chaudhary, P., Proulx, J. M., & Park, I.-W. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199191 · Cited by 16

Design stars: how Small DNA Viruses Remodel the Host Nucleus

Jiang, M., & Imperiale, M. J. (2012) · Future Virology · doi:10.2217/fvl.12.38 · Cited by 16

Towards an understanding of Angelman syndrome in mice studies

Yang, X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24576 · Cited by 18

A Comprehensive Proteomics Analysis of the JC Virus (JCV) Large and Small Tumor Antigen Interacting Proteins: Large T Primarily Targets the Host Protein Complexes with V-ATPase and Ubiquitin Ligase Activities While Small t Mostly Associates with Those Having Phosphatase and Chromatin-Remodeling Functions

Saribas, S., & Safak, M. (2020) · Viruses · doi:10.3390/v12101192 · Cited by 18

The carboxyl-terminal zinc-binding domain of the human papillomavirus E7 protein can be functionally replaced by the homologous sequences of the E6 protein

Mavromatis, K. O., Jones, D. L., Mukherjee, R., Yee, C., Grace, M. R., & Münger, K. (1997) · Virus Research · doi:10.1016/s0168-1702(97)00090-7 · Cited by 16

Papillomavirus E7 Oncoproteins Share Functions with Polyomavirus Small T Antigens

White, E. A., Kramer, R. E., Hwang, J. H., Pores‐Fernando, A. T., Naetar, N., Hahn, W. C., Roberts, T. M., Schaffhausen, B. S., Livingston, D. M., & Howley, P. M. (2014) · Journal of Virology · doi:10.1128/jvi.03282-14 · Cited by 16

Assessing parallel gene histories in viral genomes

Mengual‐Chuliá, B., Bedhomme, S., Lafforgue, G., Elena, S. F., & Bravo, I. G. (2016) · BMC Evolutionary Biology · doi:10.1186/s12862-016-0605-4 · Cited by 16

Gordon Wilson Lecture: Infectious Disease Causes of Cancer: Opportunities for Prevention and Treatment.

Howley, P. M. (2015) · Europe PMC (PubMed Central) · Cited by 16

Interferon‐Inducible Genes Are Major Targets of Human Papillomavirus Type 31: Insights from Microarray Analysis

Chang, Y. E., & Laimins, L. A. (2001) · Disease Markers · doi:10.1155/2001/398542 · Cited by 16

p53 immunoreactivity in non‐melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours

Khorshid, S. M., Glover, M., Churchill, L. J., McGregor, J. M., & Proby, C. M. (1996) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1996.tb01471.x · Cited by 16

DNA damage response is hijacked by human papillomaviruses to complete their life cycle

Hong, S.-Y. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600306 · Cited by 17

FOXL2 and FOXA1 cooperatively assemble on the TP53 promoter in alternative dimer configurations

Choi, Y., Luo, Y., Lee, S., Jin, H., Yoon, H., Hahn, Y., Bae, J., & Lee, H. H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac673 · Cited by 15

The role of human papillomavirus in the development of pyogenic granulomas

Miller, A., Sahl, W. J., Brown, S. A., Young, S. K., Quinlan, C., Patel, P., Benbrook, D. M., & Naylor, M. F. (1997) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1997.00283.x · Cited by 15

Human Papillomavirus E6 Regulates the Cytoskeleton Dynamics of Keratinocytes through Targeted Degradation of p53

Cooper, B., Brimer, N., & Pol, S. V. (2007) · Journal of Virology · doi:10.1128/jvi.01083-07 · Cited by 15

Chelating Agents Stabilize the Monomeric State of the Zinc Binding Human Papillomavirus 16 E6 Oncoprotein

Degenkolbe, R., Gilligan, P. C., Gupta, S., & Bernard, H. U. (2003) · Biochemistry · doi:10.1021/bi027390h · Cited by 15

Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer

Kumar, A., Rathi, E., Hariharapura, R. C., & Kini, S. G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21697 · Cited by 14

Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma

O’Neill, W. Q., Xie, X., Gui, S., Yu, H., Davenport, J., Cartwright, T., Storl-Desmond, M. R., Ryu, E., Chan, E. R., Cao, S., et al. (2022) · Cancers · doi:10.3390/cancers14020282 · Cited by 14

Modulation of Autophagy-Like Processes by Tumor Viruses

Mack, H. I. D., & Münger, K. (2012) · Cells · doi:10.3390/cells1030204 · Cited by 14

Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation

Dacus, D., & Wallace, N. A. (2021) · Viruses · doi:10.3390/v13081662 · Cited by 17

Mutagenic Potential ofBos taurusPapillomavirus Type 1 E6 Recombinant Protein: First Description

Araldi, R. P., Mazzuchelli-de-Souza, J., Módolo, D. G., de Souza, E. B., de Melo, T. C., Spadacci-Morena, D. D., Magnelli, R. F., de Carvalho, M. A. C. R., Júnior, P. L. D. S., de Carvalho, R. F., et al. (2015) · BioMed Research International · doi:10.1155/2015/806361 · Cited by 14

Crystal structure of the catalytic C‐lobe of the HECT‐type ubiquitin ligase E6AP

Ries, L. K., Liess, A. K. L., Feiler, C. G., Spratt, D. E., Lowe, E. D., & Lorenz, S. (2020) · Protein Science · doi:10.1002/pro.3832 · Cited by 14

Human Cervical Cancer

Eckert, R. L., Agarwal, C., Hembree, J. R., Choo, C. K., Sizemore, N., Leyen, S. A., & Rorke, E. A. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0949-7_3 · Cited by 14

Numerical aberrations of chromosome 1 in cervical intraepithelial neoplasia are strongly associated with infection with high‐risk human papillomavirus types

Bulten, J., Melchers, W. J. G., Kooy‐Smits, M. M., de Wilde, P. C., Poddighe, P. J., Robben, J. C. M., Macville, M. V. E., Massuger, L. F. A. G., Bakkers, J. M. J. E., & Hanselaar, A. G. J. M. (2002) · The Journal of Pathology · doi:10.1002/path.1222 · Cited by 14

A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor

Barmchi, M. P., Gilbert, M., Thomas, M., Banks, L., Zhang, B., & Auld, V. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005789 · Cited by 15

Peptides as Targeting Agents and Therapeutics: A Brief Overview

Warthen, J. L., & Lueckheide, M. J. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00518 · Cited by 13

Association of cottontail rabbit papillomavirus E6 oncoproteins with the hDlg/SAP97 tumor suppressor

Du, M., Fan, X., Hanada, T., Gao, H., Lutchman, M., Brandsma, J. L., Chishti, A. H., & Chen, J. J. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20383 · Cited by 13

Degradation of HPV20E6 by p53: ΔNp63α and mutant p53R248W protect the wild type p53 mediated caspase‐degradation

Fei, J., & de Villiers, E. (2008) · International Journal of Cancer · doi:10.1002/ijc.23506 · Cited by 13

DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas

Holcomb, A. J., Brown, L. E., Tawfik, O. W., Madan, R., Shnayder, Y., Thomas, S. M., & Wallace, N. A. (2020) · Virology · doi:10.1016/j.virol.2020.07.004 · Cited by 13

Sterile α Motif Domain Containing 9 Is a Novel Cellular Interacting Partner to Low-Risk Type Human Papillomavirus E6 Proteins

Wang, J., Dupuis, C. J., Tyring, S. K., & Underbrink, M. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149859 · Cited by 13

Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins

Yapindi, L., Bowley, T. Y., Kurtaneck, N., Bergeson, R. L., James, K., Wilbourne, J., Harrod, C. K., Hernandez, B. Y., Emerling, B. E., Yates, C., et al. (2023) · Virology · doi:10.1016/j.virol.2023.05.004 · Cited by 15

Genotoxic consequences of viral infections

Szewczyk-Roszczenko, O. K., Roszczenko, P., Vassetzky, Y. S., & Sjakste, N. (2025) · npj Viruses · doi:10.1038/s44298-024-00087-5 · Cited by 13

Human papillomavirus association with head and neck cancers: understanding virus biology and using it in the development of cancer diagnostics

Strati, K., & Lambert, P. F. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.1.11 · Cited by 12

HPV16 E6 regulates annexin 1 (ANXA1) protein expression in cervical carcinoma cell lines

Calmon, M. F., Sichero, L. C., Boccardo, E., Villa, L. L., & Rahal, P. (2016) · Virology · doi:10.1016/j.virol.2016.05.016 · Cited by 12

Orthogonal ubiquitin transfer reveals human papillomavirus E6 downregulates nuclear transport to disarm interferon‐γ dependent apoptosis of cervical cancer cells

Wang, Y., Liu, R., Liao, J., Jiang, L., Jeong, G. H., Zhou, L., Polite, M., Duong, D. M., Seyfried, N. T., Wang, H., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101232rr · Cited by 12

Loss of the E6AP Ubiquitin Ligase Induces p53-Dependent Phosphorylation of Human Papillomavirus 18 E6 in Cells Derived from Cervical Cancer

Vats, A., Skrabar, N., Sal, G. D., & Banks, L. (2022) · Journal of Virology · doi:10.1128/jvi.01503-21 · Cited by 12

The Lens: Historical and Comparative Perspectives

Robinson, M. L., & Lovicu, F. J. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.002 · Cited by 12

Expression and Assay of HECT Domain Ligases

Beaudenon, S. L., Dastur, A., & Huibregtse, J. M. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)98011-7 · Cited by 12

Cloning and Expression of the cDNA for E6-AP, a Protein that Mediates the Interaction of the Human Papillomavirus E6 Oncoprotein with p53

Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.775 · Cited by 553

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416

Interaction of the E6 protein of human papillomavirus with cellular proteins.

Keen, N., Elston, R., & Crawford, L. (1994) · PubMed · Cited by 53

The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells

Talis, A. L., Huibregtse, J. M., & Howley, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6439 · Cited by 261

Requirement of e6ap and the features of human papillomavirus e6 necessary to support degradation of p53

Cooper, B., Schneider, S., Bohl, J., Jiang, Y.-H., Beaudet, A. L., & Pol, S. V. (2003) · Virology · doi:10.1016/s0042-6822(02)00012-0 · Cited by 86